QOL Medical is a specialty biopharmaceutical company dedicated to improving each patient’s life. We focus on solving complex, rare disease challenges with elegant solutions and want to change the world, one patient at a time.
Our Products
Sucraid®
(sacrosidase)
Oral Solution
VISIT PRODUCT SITE
Ethamolin®
(ethanolamine
oleate)
Injection 5%
VISIT PRODUCT SITE
Gimoti®
(metoclopramide) nasal spray
BOXED WARNING: TARDIVE DYSKINESIA
- Metoclopramide, including GIMOTI®, can cause tardive dyskinesia (TD), a potentially irreversible serious movement disorder. In patients treated with metoclopramide, including GIMOTI®, the risk of developing TD increases with duration of treatment and total cumulative dosage.
- GIMOTI® is contraindicated in patients with a history of TD.
- Use GIMOTI® for the shortest duration of treatment and periodically reassess the need for continued treatment.
- Immediately discontinue GIMOTI® in patients who develop signs or symptoms of TD.
- Avoid a total duration of treatment with metoclopramide products, including GIMOTI®, for longer than 12 weeks. If longer-term use is unavoidable, routinely monitor for signs and symptoms of TD.